Guiqing Yao
Biographic Data
| ID | 8984180 |
|---|---|
| NAME | Guiqing Yao |
| GIVEN NAMES | Guiqing |
| FAMILY NAME | Yao |
| SIGNATURE | YAO G |
| AFFILIATIONS | Department of Cardiovascular Sciences and Leicester Clinical Trial Unit, College of Life Sciences University of Leicester Leicester UK |
| ORCID | 0000-0002-9095-6676 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Patient versus physician preferences for lipid‐lowering drug therapy
BACKGROUND: The emergence of proprotein convertase subtilisin/kexin type 9 inhibitors offered dyslipidemia patients an alternative to statins for lipid-lowering treatment. Understanding patient and physician preferences for lipid-lowering drugs may promote shared decision-making and improve treatment outcomes. METHODS: This study utilized an online discrete choice experiment (DCE) to assess the relative importance (RI) of six attributes related t…
Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85
Introduction: Multidomain interventions to address modifiable risk factors for dementia are promising, but require more cost-effective, scalable delivery. This study investigated the feasibility of the "Active Brains" digital behavior change intervention and its trial procedures. Materials and methods: = 180) adults aged 60-85. Results: We collected 67.2 and 76.1% of our 12-month primary outcome (Baddeley verbal reasoning task) data for the "lowe…
No prominent works on this page.
Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85
Introduction: Multidomain interventions to address modifiable risk factors for dementia are promising, but require more cost-effective, scalable delivery. This study investigated the feasibility of the "Active Brains" digital behavior change intervention and its trial procedures. Materials and methods: = 180) adults aged 60-85. Results: We collected 67.2 and 76.1% of our 12-month primary outcome (Baddeley verbal reasoning task) data for the "lowe…
Patient versus physician preferences for lipid‐lowering drug therapy
BACKGROUND: The emergence of proprotein convertase subtilisin/kexin type 9 inhibitors offered dyslipidemia patients an alternative to statins for lipid-lowering treatment. Understanding patient and physician preferences for lipid-lowering drugs may promote shared decision-making and improve treatment outcomes. METHODS: This study utilized an online discrete choice experiment (DCE) to assess the relative importance (RI) of six attributes related t…
Medicine (2 works) · Psychology (2 works) · Clinical Psychology (1 work) · Cognition (1 work) · Cognitive decline (1 work) · Cognitive Intervention (1 work) · Cognitive Training (1 work) · Dementia (1 work) · Dementia and Cognitive Impairment Research (1 work) · Digital Mental Health Interventions (1 work)